AN2 Therapeutics
ANTX
#8920
Rank
C$0.27 B
Marketcap
C$7.29
Share price
-2.68%
Change (1 day)
373.99%
Change (1 year)

Earnings for AN2 Therapeutics (ANTX)

Earnings in 2026 (TTM): -C$54.06 Million

According to AN2 Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$54.66 Million, an increase over its 2024 earnings that were of -C$78.24 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AN2 Therapeutics from 2021 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$54.06 Million-1.09%
2025 -C$54.66 Million-30.14%
2024 -C$78.24 Million-21.66%
2023 -C$99.87 Million64.77%
2022 -C$60.61 Million95.89%
2021 -C$30.94 Million